Aerie Pharma (AERI) –
-
Form 15-12G AERIE PHARMACEUTICALS
-
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
-
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: McHugh Julie
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: MCGRAW BENJAMIN F III
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: McDonnell Peter J
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: Kopczynski Casey C.
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: Lang Peter Frederick
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: LaRocca John
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: GRYSKA DAVID W
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: du Toit Michael
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: Croarkin Richard
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: Calabrese Jeffrey
-
Form 4 AERIE PHARMACEUTICALS For: Nov 21 Filed by: KANNAN RAJ
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form S-8 POS AERIE PHARMACEUTICALS
-
Form 8-K AERIE PHARMACEUTICALS For: Nov 21
-
Form 25-NSE AERIE PHARMACEUTICALS Filed by: Nasdaq Stock Market LLC
-
Form 8-K AERIE PHARMACEUTICALS For: Nov 17
-
Form SC 13G/A AERIE PHARMACEUTICALS Filed by: MORGAN STANLEY
-
Form DEFA14A AERIE PHARMACEUTICALS
-
Form 8-K AERIE PHARMACEUTICALS For: Nov 07
-
Form 10-Q AERIE PHARMACEUTICALS For: Sep 30
-
Form 4 AERIE PHARMACEUTICALS For: Nov 01 Filed by: Calabrese Jeffrey
-
Form 8-K AERIE PHARMACEUTICALS For: Nov 01
-
Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
Form DEFM14A AERIE PHARMACEUTICALS
-
Form PREM14A AERIE PHARMACEUTICALS For: Sep 21
-
Form 8-K AERIE PHARMACEUTICALS For: Sep 13
-
Aerie Pharmaceuticals to Host Key Opinion Leader Event on Dry Eye Disease: Current Landscape, Unmet Needs, and Emerging Treatment Options
-
UPDATE: Citi Downgrades Aerie Pharma (AERI) to Neutral
-
H.C. Wainwright Downgrades Aerie Pharma (AERI) to Neutral
-
Form DEFA14A AERIE PHARMACEUTICALS
-
Form 8-K AERIE PHARMACEUTICALS For: Aug 22
-
Form DEFA14A AERIE PHARMACEUTICALS
-
Truist Securities Downgrades Aerie Pharma (AERI) to Hold
-
Pre-Open Movers: Twitter Falls on Whistleblower, Palo Alto Surges on Earnings
-
Stifel Downgrades Aerie Pharma (AERI) to Hold
-
Needham & Company Downgrades Aerie Pharma (AERI) to Hold
-
Alcon (ALC) Acquires Aerie Pharmaceuticals (AERI) for $15.25/sh or $770M
-
Form DEFA14A AERIE PHARMACEUTICALS
-
Form 8-K AERIE PHARMACEUTICALS For: Aug 22
-
Cantor Fitzgerald Downgrades Aerie Pharma (AERI) to Neutral
-
Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio
Back to AERI Stock Lookup